Cover Image

Editorial: Biomarkers in Drug Hypersensitivity

Saved in:

Bibliographic Details
Main Authors:	José A. G. Agúndez (Author), Silvia Selinski (Author), Emanuela Corsini (Author), Klaus Golka (Author), Elena García-Martín (Author)
Format:	Book
Published:	Frontiers Media S.A., 2017-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Biomarkers in Drug Hypersensitivity
by: Emanuela Corsini
Published: (2017)

Variability of the Genes Involved in the Cellular Redox Status and Their Implication in Drug Hypersensitivity Reactions
by: Pedro Ayuso, et al.
Published: (2021)

IN VITRO MODELS TO EVALUATE DRUG-INDUCED HYPERSENSITIVITY: POTENTIAL TEST BASED ON ACTIVATION OF DENDRITIC CELLS
by: Valentina Galbiati, et al.
Published: (2016)

Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021
by: José A. G. Agúndez, et al.
Published: (2022)

Detoxifying enzymes at the cross-roads of inflammation, oxidative stress and drug hypersensitivity: role of glutathione transferase P1-1 and aldose reductase
by: Francisco J Sánchez-Gómez, et al.
Published: (2016)

Editorial: Drug Hypersensitivity: From Mechanisms to Improved Diagnosis and Standards of Care
by: T. D. Fernandez, et al.
Published: (2021)

Editorial: The Potential of Machine Learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology
by: Augusto Garcia-Agundez, et al.
Published: (2022)

Editorial: The Potential of Machine-learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology: Volume II
by: Augusto Garcia-Agundez, et al.
Published: (2023)

Editorial: Editor's feature: negative findings in pharmacogenetics and pharmacogenomics
by: José A. G. Agúndez, et al.
Published: (2023)

Risk factors for drug hypersensitivity reactions in children
by: Francesca Mori, et al.
Published: (2024)

Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs
by: Yolanda Macías, et al.
Published: (2021)

Drug Hypersensitivity Associated with Dental Treatments
by: Ricardo Dias de Castro, et al.
Published: (2024)

Drug Induced Hypersensitivity and the HLA Complex
by: Munir Pirmohamed, et al.
Published: (2010)

Clinical practice guidelines for translating pharmacogenomic knowledge to bedside. Focus on anticancer drugs.
by: José A G Agúndez, et al.
Published: (2014)

Pharmacogenetic Factors Affecting Asthma Treatment Response. Potential Implications for Drug Therapy
by: Jesús Miguel García-Menaya, et al.
Published: (2019)

Editorial: Liquid-biopsy-guided biomarker and drug discovery
by: Olesya A. Kharenko, et al.
Published: (2024)

Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the Spanish Society of Clinical Pharmacology.
by: José A.G. eAgúndez, et al.
Published: (2012)

Editorial: NSAIDs Pharmacogenomics
by: José A. G. Agúndez, et al.
Published: (2021)

An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity
by: Ana Copaescu, et al.
Published: (2021)

Drug hypersensitivity reactions and allergy in patients with mastocytosis
by: Justyna H. Czarny, et al.
Published: (2017)

Cutaneous drug hypersensitivity : Immunological and genetic perspective
by: Kisalay Ghosh, et al.
Published: (2011)

Drug Hypersensitivity due to Azathioprine with Elevated Procalcitonin
by: Tania Ahuja, et al.
Published: (2018)

Pharmacogenetics and predictive testing of drug hypersensitivity reactions
by: Ruwen Boehm, et al.
Published: (2016)

Biomarkers of PEGylated Liposomal Doxorubicin-Induced Hypersensitivity Reaction in Breast Cancer Patients Based on Metabolomics
by: Wei Zhuang, et al.
Published: (2022)

Drug-Induced Hypersensitivity Syndrome Followed by Subacute Thyroiditis
by: Mika Sato, et al.
Published: (2015)

Hypothyroidism as a late manifestation of drug hypersensitivity syndrome
by: Shastry Veeranna, et al.
Published: (2010)

Hepatic necrosis associated with drug-induced hypersensitivity syndrome
by: Fernando Peixoto Ferraz de Campos, et al.
Published: (2012)

Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs: An Update
by: Luis González-Aveledo, et al.
Published: (2010)

Platelet-Adherent Leukocytes Associated With Cutaneous Cross-Reactive Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs
by: Raquel Jurado-Escobar, et al.
Published: (2020)

Abacavir: it's use and hypersensitivity
by: Helena Rabie, et al.
Published: (2009)

Hypersensitivity to Intravenous Iron Preparations
by: Silvia Caimmi, et al.
Published: (2022)

Model Based Evaluation of Hypersensitivity Adverse Drug Reactions to Antimicrobial Agents in Children
by: Abdelbaset A. Elzagallaai, et al.
Published: (2021)

Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia.
by: Hana Krismawati, et al.
Published: (2020)

The problem of hypersensitivity to local anesthetics
by: S. V. Zaikov, et al.
Published: (2020)

The problem of hypersensitivity to vitamin preparations
by: S.V. Zaikov, et al.
Published: (2021)

Incidence of Hypersensitivity Reactions During Hemodialysis
by: Raquel Esteras, et al.
Published: (2018)

Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis
by: W. Grassi, et al.
Published: (2011)

Practical Approach to Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Children
by: Daniela Podlecka, et al.
Published: (2023)

IONTOPHORESIS ON HYPERSENSITIVE DENTINE
by: Nugrohowati Nugrohowati
Published: (2015)

Antibiotic Hypersensitivity Mechanisms
by: Jenana H. Maker, et al.
Published: (2019)